Synthesis and evaluation of water-soluble polyethylene glycol-paclitaxel conjugate as a paclitaxel prodrug

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Anti-Cancer Drugs

• Publication date

  1996-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1097/00001813-199608000-00004PMID 8913432
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol

  1995cited by this paper
• Paclitaxel (taxol)

  1995cited by this paper
• Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity

  1994cited by this paper
• Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo.

  1992cited by this paper
• Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor activity.

  1992cited by this paper
• Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer.

  1990cited by this paper
• Hypersensitivity reactions from taxol.

  1990cited by this paper
• Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes

  1990cited by this paper
• Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity.

  1989cited by this paper
• Comparison of antitumor effects of daunorubicin covalently linked to poly-L-amino acid carriers.

  1984cited by this paper
• A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.

  1982cited by this paper

• Synthesis and Evaluation of Trehalose‐Based Mertansine Warheads for Bacillus Calmette–Guérin Delivery of Anticancer Agents

  2025cites this paper
• GSH-responsive paclitaxel prodrug used in chemotherapy in combination with photodynamic therapy.

  2025cites this paper
• Advances in Drug Delivery Systems for Lipophilic Drug Paclitaxel: Developments, Challenges, and Opportunities (A Review)

  2024cites this paper
• Paclitaxel Drug Delivery Systems: Focus on Nanocrystals’ Surface Modifications

  2022cites this paper
• Solubilization Methods for Paclitaxel and Docetaxel: An Overview

  2021cites this paper
• Bio-Nano Interfacial Interactions for Drug Delivery Systems

  2019cites this paper
• Nanooncology: Engineering nanomaterials for cancer therapy and diagnosis

  2018influential citation
• Chapter 18 – Carbon nanotubes: Applications in cancer therapy and drug delivery research

  2018cites this paper
• Imaging and Treating Cancer with Carbon Nanotube Technology

  2018cites this paper
• Water-soluble and amphiphilic phospholipid copolymers having 2-methacryloyloxyethyl phosphorylcholine units for the solubilization of bioactive compounds

  2018cites this paper
• Multivalent Presentation of Peptide Targeting Groups Alters Polymer Biodistribution to Target Tissues.

  2018cites this paper
• Erythrocyte Membrane-Wrapped pH Sensitive Polymeric Nanoparticles for Non-Small Cell Lung Cancer Therapy.

  2017cites this paper
• Carbon nanomaterials in oncology: an expanding horizon.

  2017cites this paper
• Applications of Functionalized Carbon Nanotubes for the Therapy and Diagnosis of Cancer

  2017cites this paper
• WATER SOLUBLE PACLITAXELDERVATIVES CROSS-REFERENCE TO RELATED PATENT APPLICATIONS

  2017cites this paper
• Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy.

  2017cites this paper
• Lipobeads as Future Drug Delivery System

  2016cites this paper
• Carbon nanotubes as cancer therapeutic carriers and mediators

  2016cites this paper
• Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer

  2016cites this paper
• Design and cell cytotoxicity assessment of palmitoylated polyethylene glycol‐grafted chitosan as nanomicelle carrier for paclitaxel

  2016cites this paper
• Developing Precisely Defined Drug‐Loaded Nanoparticles by Ring‐Opening Polymerization of a Paclitaxel Prodrug

  2016cites this paper
• Design, Synthesis, and Biological Evaluation of New Cathepsin B-Sensitive Camptothecin Nanoparticles Equipped with a Novel Multifuctional Linker.

  2016cites this paper
• Polymeric pharmaceutical forms – the forms of the future

  2015cites this paper
• Octa-ammonium POSS-conjugated single-walled carbon nanotubes as vehicles for targeted delivery of paclitaxel

  2015cites this paper
• A degradable brush polymer-drug conjugate for pH-responsive release of doxorubicin

  2015cites this paper
• Synthesis of Bis{(S-methyl)azolespoly(ethylene oxide)} from 3,6-dioxa-1,8-octanedithiol

  2015cites this paper
• Polymer–Drug Conjugates for Targeted Drug Delivery

  2015cites this paper
• Programmed Hydrolysis in Designing Paclitaxel Prodrug for Nanocarrier Assembly

  2015cites this paper
• CARBON NANOTUBES: A NOVAL CARRIER SYSTEM FOR DRUG DELIVERY & CANCER THERAPY

  2014cites this paper
• Biological effects of conjugated linoleic acid on obesity-related cancers.

  2014cites this paper
• 3. Polymer–Drug Conjugates

  2014cites this paper
• Anti-HIV drug conjugates for enhanced mucosal pre-exposure prophylaxis

  2014cites this paper
• Preparation and characterization of novel poly(ethylene glycol) paclitaxel derivatives.

  2013cites this paper
• Polymer-Drug Conjugates

  2013cites this paper
• Gemcitabine versus Modified Gemcitabine: a review of several promising chemical modifications.

  2013cites this paper
• Gemcitabine versus modified gemcitabine : a review of several promising chemical modifications

  2013cites this paper
• Carbon nanotubes for delivery of small molecule drugs.

  2013cites this paper
• The anticancer agent PTX

  2012cites this paper
• Designing Paclitaxel Drug Delivery Systems Aimed at Improved Patient Outcomes: Current Status and Challenges

  2012cites this paper
• Poly (L-glutamic acid)-Paclitaxel Conjugates for Cancer Treatment

  2012cites this paper
• Poly(alkylene H-phosphonate)s

  2012cites this paper
• Chapter 20 – Carbon Nanotubes in Cancer Therapy and Drug Delivery

  2012cites this paper
• Analytical measurement of PEGylated molecules.

  2012cites this paper
• Macromolecules as taxane delivery systems

  2011cites this paper
• The interactive potential of polyethylene oxide as a tool to adjust drug delivery

  2011cites this paper
• Carbon Nanotubes in Cancer Therapy and Drug Delivery

  2011cites this paper
• Prodrugs - an efficient way to breach delivery and targeting barriers.

  2011cites this paper
• Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy.

  2010cites this paper
• Measurement of poly(ethylene glycol) by cell-based anti-poly(ethylene glycol) ELISA.

  2010cites this paper
• Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane

  2009cites this paper
• Drug delivery with carbon nanotubes for in vivo cancer treatment.

  2008cites this paper
• Lipolysis is stimulated by PEGylated conjugated linoleic acid through the cyclic adenosine monophosphate‐independent signaling pathway in 3T3‐L1 cells: Activation of MEK/ERK MAPK signaling pathway and hyper‐secretion of adipo‐cytokines

  2008cites this paper
• Design, Synthesis and Applications of Hyaluronic Acid-Paclitaxel Bioconjugates†

  2008cites this paper
• Synthesis and evaluation of water-soluble poly(vinyl alcohol)-paclitaxel conjugate as a macromolecular prodrug.

  2008cites this paper
• Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: a phase I and feasibility trial of the Gynecologic Oncology Group.

  2008cites this paper
• In vivo antitumor activity of novel water-soluble taxoids.

  2008cites this paper
• Synthesis and applications of heterobifunctional poly(ethylene oxide) oligomers

  2008cites this paper
• Overcoming Poor Aqueous Solubility of Drugs for Oral Delivery

  2007cites this paper
• Regulation of adipocyte differentiation by PEGylated all-trans retinoic acid: reduced cytotoxicity and attenuated lipid accumulation.

  2007cites this paper
• Enabling Synthesis Toward the Production of Biocompatible Magnetic Nanoparticles With Tailored Surface Properties

  2007cites this paper
• Down-regulation of PPARgamma2-induced adipogenesis by PEGylated conjugated linoleic acid as the pro-drug: Attenuation of lipid accumulation and reduction of apoptosis.

  2006cites this paper
• Polymer therapeutics for cancer : Current status and future challenges

  2006cites this paper
• Paclitaxel prodrugs: toward smarter delivery of anticancer agents.

  2006cites this paper
• Important Classes of Compounds

  2006cites this paper
• Intravenous administration of paclitaxel in Sprague‐Dawley rats: what is a safe dose?

  2006cites this paper
• Phase I Study of CT-2103, A Polymer-Conjugated Paclitaxel, and Carboplatin in Patients with Advanced Solid Tumors

  2005cites this paper
• Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol.

  2005cites this paper
• Enhanced anticancer efficacy of α-tocopheryl succinate by conjugation with polyethylene glycol

  2005cites this paper
• Anti-tumor activity of paclitaxel prodrug conjugated with polyethylene glycol

  2005cites this paper
• Paclitaxel poliglumex. Cell Therapeutics/Chugai Pharmaceutical.

  2005cites this paper
• A new and simply available class of hydrosoluble bioconjugates by coupling paclitaxel to hyaluronic acid through a 4-hydroxybutanoic acid derived linker

  2005cites this paper
• Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure.

  2004cites this paper
• Tocol emulsions for drug solubilization and parenteral delivery.

  2004cites this paper
• Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.

  2003cites this paper
• Pegylation: Engineering Improved Biopharmaceuticals for Oncology

  2003cites this paper
• Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy.

  2003cites this paper
• Synthesis and in vitro efficacy of acid-sensitive poly(ethylene glycol) paclitaxel conjugates.

  2003cites this paper
• Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting.

  2003cites this paper
• Macromolecular Therapeutics

  2003cites this paper
• The chemistry of taxol and related taxoids.

  2002cites this paper
• Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations.

  2002cites this paper
• Tumor specific novel taxoid-monoclonal antibody conjugates.

  2002cites this paper
• The role of pro-drug therapy in the treatment of cancer.

  2001cites this paper
• Drug-targeting strategies in cancer therapy.

  2001cites this paper
• Progress in the Development of Alternative Pharmaceutical Formulations of Taxanes

  2001cites this paper
• Dextrins as Carriers for Drug Targeting: Reproducible Succinoylation as a Means to Introduce Pendant Groups

  2001cites this paper
• A differential scanning calorimetry study of phosphocholines mixed with paclitaxel and its bromoacylated taxanes.

  2000cites this paper
• Poly(ethylene glycol) conjugated drugs and prodrugs: a comprehensive review.

  2000cites this paper
• Inhibition of tumor growth by poly(ethylene glycol) derivatives of anti-ErbB2 antibodies

  2000cites this paper
• Biodistribution of paclitaxel and poly(l-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor

  2000cites this paper
• Formulation Development and Antitumor Activity of a Filter-Sterilizable Emulsion of Paclitaxel

  2000cites this paper
• Novel therapeutic nano-particles (lipocores): trapping poorly water soluble compounds.

  2000cites this paper
• The place of polymer prodrugs in cancer therapy

  2000cites this paper
• The in vitro evaluation of polyethylene glycol esters of hydrocortisone 21-succinate as ocular prodrugs.

  1999cites this paper
• Paclitaxel derivatives for targeted therapy of cancer: toward the development of smart taxanes.

  1999cites this paper
• Intracellular pharmacokinetics of Paclitaxel : relationship with Pharmacodynamics and therapeutic implications /

  1999cites this paper
• Cell-killing by paclitaxel in a metastatic murine melanoma cell line is mediated by extensive telomere erosion with no decrease in telomerase activity.

  1999cites this paper
• Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate.

  1998cites this paper
• Determination of polyethylene glycol activated with cyanuric chloride in liposomes.

  1997cites this paper